| Subsequent Endpoints | Tacrolimus Monotherapy (n=148) | Tacrolimus + MMF (n=77) | P-value |
|---|---|---|---|
| 3-Year Survival | 90.5% | 89.6% | 0.789 |
| 3-Year Freedom from CAV | 89.2% | 84.4% | 0.300 |
| 3-Year Freedom from NF-MACE | 89.9% | 89.6% | 0.896 |
| 1-Year Freedom from ATR | 96.6% | 97.4% | 0.733 |
| 1-Year Freedom from ACR | 96.6% | 98.7% | 0.352 |
| 1-Year Freedom from AMR | 98.6% | 97.3% | 0.487 |
| 3-Year Freedom from Cardiac Dysfunction | 98.6% | 98.7% | 0.972 |